Pharmacokinetic Evaluation of Metabolic Drug Interactions between Repaglinide and Celecoxib by a Bioanalytical HPLC Method for Their Simultaneous Determination with Fluorescence Detection

Since diabetes mellitus and osteoarthritis are highly prevalent diseases, combinations of antidiabetic agents like repaglinide (REP) and non-steroidal anti-inflammatory drugs (NSAID) like celecoxib (CEL) could be commonly used in clinical practice. In this study, a simple and sensitive bioanalytical...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Dong-Gyun, Kwak, Jinsook, Seo, Seong-Wook, Kim, Ji-Min, Yoo, Jin-Wook, Jung, Yunjin, Lee, Yun-Hee, Kim, Min-Soo, Jung, Young-Suk, Yun, Hwayoung, Yoon, In-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723536/
https://www.ncbi.nlm.nih.gov/pubmed/31382371
http://dx.doi.org/10.3390/pharmaceutics11080382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723536/
https://www.ncbi.nlm.nih.gov/pubmed/31382371
http://dx.doi.org/10.3390/pharmaceutics11080382

Ejemplares similares